Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor.
about
Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesisIntegrated physiology and systems biology of PPARαAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseMitochondrial biogenesis and dynamics in the developing and diseased heartAcylcarnitines: reflecting or inflicting insulin resistance?A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disordersUpstream stimulatory factor represses the induction of carnitine palmitoyltransferase-Ibeta expression by PGC-1New parenteral lipid emulsions for clinical useFailure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitusLong-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathwayNovel role of FATP1 in mitochondrial fatty acid oxidation in skeletal muscle cellsDietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats.Differential regulation of the expressions of the PGC-1α splice variants, lipins, and PPARα in heart compared to liver.Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes.A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate.Filling gaps in PPAR-alpha signaling through comparative nutrigenomics analysis.Skeletal Muscle Nucleo-Mitochondrial Crosstalk in Obesity and Type 2 Diabetes.Lower Expression of SLC27A1 Enhances Intramuscular Fat Deposition in Chicken via Down-Regulated Fatty Acid Oxidation Mediated by CPT1A.Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutationsRegulation of lipid and lipoprotein metabolism by PPAR activators.PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flowRegulatory potential of n-3 fatty acids in immunological and inflammatory processes.Tissue-specific 5' heterogeneity of PPARα transcripts and their differential regulation by leptin.Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro.Genetic-dependency of peroxisomal cell functions - emerging aspects.PPARalpha agonist-induced rodent tumors: modes of action and human relevance.Maintaining ancient organelles: mitochondrial biogenesis and maturation.Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review.Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.Olive Leaf Extract Elevates Hepatic PPAR α mRNA Expression and Improves Serum Lipid Profiles in Ovariectomized Rats.Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties.Inhibition of smooth muscle proliferation by urea-based alkanoic acids via peroxisome proliferator-activated receptor alpha-dependent repression of cyclin D1.Effects of dietary fatty acids on insulin sensitivity and secretion.Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle.Cardiac PPARalpha Protein Expression is Constant as Alternate Nuclear Receptors and PGC-1 Coordinately Increase During the Postnatal Metabolic Transition.Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes.Energy sensing and regulation of gene expression in skeletal muscle.L-carnitine preserves endothelial function in a lamb model of increased pulmonary blood flow
P2860
Q24531410-BA5B8031-CB95-47A2-863B-393EE51ED397Q24564130-C745220B-9303-4E60-B32E-5A54B8F20FBCQ24803926-2228FE59-908F-47B5-A017-7E94B8A034F0Q26782031-5F735C8E-959E-414F-A003-39FCCC18B79AQ27004603-23DA6B98-6501-4B60-BB84-4CAECBFD92A5Q28116120-65851E73-68CF-4567-B62F-82FB64FE162AQ28213001-C267B451-EA6E-4B3A-9EA9-8BECE81EE0EAQ28248812-CE3E61E6-C008-440F-8087-47DC68453A24Q28315009-BF034E89-1D8A-4CBA-B522-6F555E3392D3Q28348167-9F6173D1-93D8-4DEF-855D-05D12BEB59BDQ28574936-A1989843-0008-464A-97A9-FEEF528DE3E5Q30319820-B5027D7B-807E-4DFE-BD7C-8D7206ECE1D1Q30412828-D7FFAECF-3870-47AB-AD0D-621E61DA3971Q31514175-E72E5065-E0C8-457F-88A4-283C64C131C2Q31833512-A6D96B18-9488-48DA-AFCB-8C97E217E958Q31965897-AD12BDA5-A99E-4ED0-ADB4-A999CA0AE59AQ33517939-04FA290A-38EC-4211-A4EC-3724D972F59BQ33624769-758AEF67-19AF-4699-8EAA-55C1F8C5B15FQ33849841-02342AF7-BCF4-4E41-AC0E-25A1A4D2069BQ33884120-337EE261-6630-4ED5-BCE9-CED2C640458FQ33896369-A0F21540-9689-465D-B790-E95ED63F583FQ34409704-2F6931BD-A6D9-4603-A6C6-D7E719F1F3D2Q34564516-D251769B-97B7-414F-9113-88BC50041CB6Q34794988-63EB099D-303B-4067-BBCD-CC5AFCCF8198Q34920348-36DD6315-669D-46DC-B9D4-F8DE992C4C52Q35004507-362BAF13-25B0-4292-B777-17D6CE94AF4AQ35574139-33785B1E-EF85-44B7-B82E-DA26B7EB66CDQ35631058-07E89AD1-9ADB-4638-8BB1-05972A0D2E51Q35645509-CBC28FE0-19D1-42AF-A66E-74E7C1A645BDQ35670863-0E571B8C-3092-4C1C-9F40-3E07A7E0F3E4Q35677716-D29C13CA-A887-4423-B61A-D202E4F16AFDQ35821715-78A22022-BFAB-476E-9106-DFC515705F03Q35862864-A8E03681-BC1A-4EE1-A06E-755995B5A9E6Q35865401-B4194830-55ED-4A4B-A17F-5B6E645F4424Q35915585-D1F31C68-E849-47AB-A80F-D4EE59B896B9Q35973475-5CD43C2E-2D23-476B-8F94-7C5B7F1739B5Q36445308-DA238245-D596-4533-96C4-EE02383EB034Q36512559-0EA0D164-0953-4368-B1DC-8F205EA59812Q36643388-7E6BD142-B9D9-45B9-9417-1D32FDEA296EQ37004620-A6C39534-D227-4C60-A382-55FA85B538E6
P2860
Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Control of human muscle-type c ...... oliferator-activated receptor.
@en
type
label
Control of human muscle-type c ...... oliferator-activated receptor.
@en
prefLabel
Control of human muscle-type c ...... oliferator-activated receptor.
@en
P2093
P356
P1476
Control of human muscle-type c ...... oliferator-activated receptor.
@en
P2093
P304
P356
10.1074/JBC.273.15.8560
P407
P577
1998-04-01T00:00:00Z